CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- 4 Open-market sale Director sold 4,560 shares at $403.36 ($1,839,322)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $385.21 ($4,237,281)
- 4 Planned sale PRESIDENT AND COO sold 22,500 shares at an average $417.64 ($9,396,837)
- 4 Planned sale Director sold 3,000 shares at an average $423.21 ($1,269,630)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $308.75 ($3,396,249)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $300.00 ($3,299,981)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 590 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
- 4 Exercise or conversion Director acquired 590 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 590 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
- 4 Exercise or conversion Director acquired 590 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,220 shares (option exercise)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $304.11 ($3,345,225)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $300.31 ($3,303,394)
- 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $285.70 ($3,142,718)
Page 20 of 164 · 3,272 filings